The company expired its plan on November 16, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,550 KRW | +1.23% | +1.99% | -0.24% |
2023 | Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
2022 | Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022. | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.24% | 361M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- A228760 Stock
- News Genomictree Inc.
- Genomictree Inc.'s Equity Buyback announced on May 17, 2022, has expired with 380,360 shares, representing 1.86% for KRW 4,984.4 million.